Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.

Garnier, Camille

Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis. [electronic resource] - The Journal of rheumatology 11 2018 - 1541-1548 p. digital

Publication Type: Journal Article

1499-2752

10.3899/jrheum.180310 doi


Adult
Aged
Antiviral Agents--therapeutic use
Cyclophosphamide--adverse effects
Female
Herpes Zoster--epidemiology
Humans
Immunosuppressive Agents--adverse effects
Incidence
Lupus Erythematosus, Systemic--complications
Male
Middle Aged
Retrospective Studies
Risk Factors
Vasculitis--complications
Young Adult